Monday, February 13, 2017

Dispute over the legal rights to an anticancer agent continues

Patent reissued for molecule at the center of a disagreement between Scripps and Oncoceutics

via Chemical & Engineering News: Biological SCENE http://ift.tt/2koXq85
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)